41717-30-0 Usage
General Description
Befuraline is a psychoactive drug and central nervous system stimulant that belongs to the class of compounds known as phenylethylamines. It acts as a selective and reversible inhibitor of the enzyme monoamine oxidase A (MAO-A), leading to increased levels of neurotransmitters such as serotonin, dopamine, and norepinephrine in the brain. This results in enhanced mood, arousal, and cognitive function. Befuraline has been studied for its potential therapeutic effects in conditions such as depression and attention deficit hyperactivity disorder (ADHD), although its use is limited due to concerns about potential side effects and interactions with other medications. The compound has also been investigated for its psychotropic properties and potential as a recreational drug.
Check Digit Verification of cas no
The CAS Registry Mumber 41717-30-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,1,7,1 and 7 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 41717-30:
(7*4)+(6*1)+(5*7)+(4*1)+(3*7)+(2*3)+(1*0)=100
100 % 10 = 0
So 41717-30-0 is a valid CAS Registry Number.
InChI:InChI=1/C20H20N2O2/c23-20(19-14-17-8-4-5-9-18(17)24-19)22-12-10-21(11-13-22)15-16-6-2-1-3-7-16/h1-9,14H,10-13,15H2
41717-30-0Relevant articles and documents
Exploration of a new series of PAR1 antagonists
Planty, Bruno,Pujol, Chantal,Lamothe, Marie,Maraval, Catherine,Horn, Clemens,Grand, Bruno Le,Perez, Michel
scheme or table, p. 1735 - 1739 (2010/07/08)
Two series of new PAR1 antagonists have been identified. The first incorporates a cinnamoylpiperidine motif and the second a cinnamoylpyridine pattern. The synthesis, biological activity and structure-activity relationship of these compounds are presented. In each series, one analog showed potent in vivo antithrombotic activity in a rat AV shunt model, with up to 53% inhibition at 1.25 mpk iv for compound 30.
